Is CI stock overvalued or undervalued?
Cigna (CI) is generally considered to be undervalued by many market analysts and valuation models when compared to the company's long-term earnings potential. Despite occasional investor disappointment following preliminary guidance or sector-specific headwinds, research firms frequently reiterate "Buy" or "Overweight" ratings, often setting price targets that suggest a substantial upside from the current trading price. Various fair value calculators and valuation models utilized by financial research platforms often reveal a gap between the stock’s current market price and its estimated intrinsic value. While no stock valuation is absolute, the prevailing market narrative—bolstered by consistent analyst price targets—frames CI as a stock that is trading below what many professionals believe is its true worth, making it a target for investors who focus on fundamental valuation metrics rather than just short-term price movements.
Related FAQs
Cipher Mining (trading under the ticker CIFR) has experienced capital structure adjustments typical of high-growth digital infrastructure and bitcoin mining enterprises, but it has not implemented a traditional retail-oriented stock split of its c...
DaVita Inc. is one of the largest kidney care and dialysis service providers in the United States, operating hundreds of outpatient centers that treat patients with chronic kidney failure.
Executive compensation for Stephen M. Spray, serving as the President and Chief Executive Officer of Cincinnati Financial Corporation, reflects leadership in the property and casualty insurance sector.
The Cigna Group (CI) is widely viewed favorably by Wall Street analysts, with a consensus rating that leans toward a "Strong Buy.
No, Cigna is not as large as UnitedHealthcare. UnitedHealthcare is the largest health insurance provider in the United States, maintaining a significant advantage in terms of scale, diversification, and overall profitability.
Yes, The Cigna Group is performing well financially. The company reported strong results for the first quarter of 2026, with total revenues of $68.5 billion, representing a 5% increase compared to the previous year.
The outlook for Cigna's stock in 2026 is generally positive, with many Wall Street analysts forecasting growth. As of late July 2026, the average price target set by analysts for Cigna Group shares is approximately $338.
Yes, Cigna announced a significant workforce reduction in early 2026. The company laid off approximately 2,000 employees, which represents just under 3% of its global workforce of about 73,500 people.
As of late July 2026, the analyst consensus for The Cigna Group (CI) stock is a "Buy.